Team uses AlphaFold AI to redesign gene-editing proteins to make them safer. Google's AlphaFold can help ID what parts of a gene editing protein enable mistakes.
A apuração publicada por arstechnica.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A couple of decades after the discovery of systems that could selectively target DNA, we're starting to see the first therapies based on gene editing. One challenge these developments have faced is safety.
- Ponto de atenção: team.
- Ponto de atenção: uses.
- Ponto de atenção: alphafold.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Tech.
